Tagrisso Approved for Some With Locally Advanced, Unresectable Stage III NSCLC Following Chemoradiation

The FDA has approved Tagrisso for adult patients with locally advanced, unresectable stage III NSCLC whose disease ...

SEPTEMBER 26, 2024